Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Giles Bryan ECHIEF FINANCIAL OFFICER | Grant or award | A | — 34.2K sh | Jan 8, 2026 |
| 17 | Henderson Tracey KExecutive VP Exploration | Grant or award | A | — 18.3K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 9,722 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Edwards Carladenise ArmbristerDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Hamilton James CChief Medical Officer | Grant or award | A | — 75.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Wu Joanne CGeneral Counsel and Secretary | Grant or award | A | — 25.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Lopez Anthony WilliamSEE REMARKS | Option exercise | M | — 17.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Frew JamesSEE REMARKS | Option exercise | M | — 55.8K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $33K 9,722 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Boone KarenDirector | Option exercise | M | — 1,460 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Borgeson BlakeDirector | Open-market sale · 10b5-1 plan | SELL | $959K 220.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Willis Eric M.See Remarks | Option exercise | M | — 29.5K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Lakkundi Veena MPres, Performance Surfaces | Grant or award | A | $50K 1,341 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Ajami DariushChief Innovation Officer | Tax withholding | F | $194K 207.3K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Giles Bryan ECHIEF FINANCIAL OFFICER | Tax withholding | F | $208K 17.6K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 16 | Frew JamesSEE REMARKS | Tax withholding | F | $109K 23.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Willis Eric M.See Remarks | Tax withholding | F | $60K 13.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Wu Joanne CGeneral Counsel and Secretary | Tax withholding | F | $149K 12.7K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 15 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $216K 1,121 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 15 | Haase Bruce NDirector | Grant or award | A | — 3,398 sh | Jan 8, 2026 traded Jan 1, 2026 |
| 15 | Marathe AjayChief Operating Officer | Tax withholding | F | $369K 42.6K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Peterson Neil W.CHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $450K 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Wall Cecil CDirector | Grant or award | A | $18K 23.1K sh | Jan 8, 2026 traded Jan 5, 2026 |
| 14 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $234K 3,016 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 14 | Schlosser MarioDirector, President of Technology & CTO | Open-market sale · 10b5-1 plan | SELL | $1.31M 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Boone KarenDirector | Option exercise | M | — 1,460 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Robinson William G JrDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Nelson Jonathan PChief Operations Officer | Tax withholding | F | $30K 32.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Arnaboldi Nicole SDirector | Grant or award | A | $36K 463 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | M | — 17.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Loengard Anna UDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Lufkin Paul AndrewSenior Vice President, Sales | Tax withholding | F | $28K 30.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Lizzul Paul F.Chief Medical Officer | Option exercise | M | — 6,145 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Foote TimChief Financial Officer | Option exercise | M | — 4,616 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $34K 4,364 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Ackerman EricaCAO and Corporate Controller | Tax withholding | F | $1,037 687 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Smith Chad M.Pres & COO, Better Mortgage | Open-market sale · 10b5-1 plan | SELL | $100K 2,843 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Kouzoukas Demetrios L.Director | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |